Preparation and evaluation of tumor-targeting peptide - Oligonucleotide conjugates

Bioconjugate Chemistry

Volumn 11, Issue 6, 2000, Pages 855-860

  Mier, W ^a   Eritja, R ^a,b,c   Mohammed, A ^a   Haberkorn, U ^a   Eisenhut, M ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^c DEPT OF ENVIRONMENTAL CHEMISTRY   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; COVALENT BOND; DRUG TARGETING; GENE OVEREXPRESSION; PROTO ONCOGENE; RECEPTOR; SOMATOSTATIN;

GENE EXPRESSION; GENE THERAPY; PEPTIDES; SULFUR COMPOUNDS; SYNTHESIS (CHEMICAL); TUMORS;

ANTISENSE OLIGODEOXYNUCLEOTIDES; CELLULAR UPTAKE; DRUG TARGETING SYSTEMS; GENES EXPRESSION; OLIGODEOXYNUCLEOTIDES; OLIGONUCLEOTIDE CONJUGATES; SOLID PHASE SYNTHESIS; SOMATOSTATIN RECEPTORS; THERAPEUTIC AGENTS; TUMOR TARGETING PEPTIDES;

OLIGONUCLEOTIDES;

EID: 0033659720     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc000041k     Document Type: Article

References (33)

1. Oligodeoxyribonucleotide uptake in primary human hematopoietic cells is enhanced by cationic lipids and depends on the hematopoietic cell subset
2. Synthesis, hybridization properties and antiviral activity of lipid-oligodeoxynucleotide conjugates
3. Tailored hydrophobic cavities in oligonucleotide-steroid conjugates
4. Enhancement of anti-herpetic activity of antisense phosphorothioate oligonucleotides 5' end modified with geraniol
5. Biological activity of oligonucleotide-poly (l-lysine) conjugates: Mechanism of cell uptake
6. Enhanced cellular uptake of biotinylated antisense oligonucleotide or peptide mediated by avidin, a cationic protein
7. Vector-mediated delivery of a polyamide ('peptide') nucleic acid analogue through the blood-brain barrier in vivo
8. Cationic porphyrins: Novel delivery vehicles for antisense oligodeoxynucleotides
9. Preparation of vitamin B6-conjugated peptides at the amino terminus and of vitamin B6-peptide-oligonucleotide conjugates
10. Antisense DNA delivery in vivo: Liver targeting by receptor-mediated uptake
11. Peptide mini-vectors for gene delivery
12. Enhanced cellular uptake of oligonucleotides by EGF receptor-mediated endocytosis in A549 cells
13. Trojan peptides: The penetratin system for intracellular delivery
14. Cellular delivery of oligonucleotides by synthetic import peptide carrier
15. Design of carrier peptide-oligonucleotide conjugates with rapid membrane translocation and nuclear localization properties
16. SMS 201-995: A very potent and selective octapeptide analogue of somatostatin with prolonged action
17. Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy
18. Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: Comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides
19. Antisense oligonucleotides suppress B-cell lymphoma growth in a SCID-hu mouse model
20. Receptor scintigraphy with a radioiodinated somatostatin analogue: Radiolabeling, purification, biologic activity, and in vivo application in animals
21. In situ neutralization in Boc-chemistry solid-phase peptide synthesis
22. 4-mercaptoethylcytosine and their use in the preparation of oligonucleotide-peptide conjugates carrying c-myc tag-sequence
23. Simplified sample preparation for the analysis of oligonucleotides by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry
24. Deprotection of S-acetamidomethyl cysteine-containing peptides by silver trifluoromethanesulfonate avoids the oxidation of methionines
25. Cyclization of disulfide-containing peptides in solid-phase synthesis
26. Generally applicable, convenient solid-phase synthesis and receptor affinities of octreotide analogs
27. A procedure for quantitative determination of tris(2-carboxyethyl)phosphine, an odorless reducing agent more stable and effective than dithiothreitol
28. Synthesis of defined peptide-oligonucleotide hybrids containing a nuclear transport signal sequence
29. Hybridization considerations affecting antisense drugs
30. Distribution of somatostatin receptor subtypes in rat lumbar spinal cord examined with gold-labeled somatostatin and antireceptor antibodies
31. 3]-octreotide: The Rotterdam experience with more than 1000 patients
32. Synthesis and biological evaluation of cytotoxic analogues of somatestatin containing doxorabicin or its intensely potent derivative, 2-pyrrolinodoxorubicin
33. Inhibition of PC-3 human androgen-independent prostate cancer and its metastases by cytotoxic somatostatin analogue AN-238